- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 15:34 | Split and Change of ISIN for Scibase Holding AB | 66 | GlobeNewswire | The company will carry out a reverse stock split in a ratio of 1:100. The share will be traded under new ISIN code with effect from Jun 4, 2026. The order book will not change.
Short... ► Artikel lesen | |
| Do | SciBase announces that the board of directors has resolved on the record date for the reverse share split | 456 | PR Newswire | STOCKHOLM, May 28, 2026 /PRNewswire/ -- SciBase Holding AB ("SciBase") (STO: SCIB), a leader in AI-based devices for detection and prevention in dermatology, today announces that the board... ► Artikel lesen | |
| Do | SciBase: Nevisense detects skin barrier damage by chemicals used in household cleaning products in a new ex-vivo study | 435 | PR Newswire | STOCKHOLM, May 28, 2026 /PRNewswire/ -- SciBase Holding AB ("SciBase") (STO: SCIB), a leader in AI-based devices for detection and prevention in dermatology, announced today the publication... ► Artikel lesen | |
| 19.05. | Bulletin from the annual general meeting in SciBase Holding AB (publ) | 310 | PR Newswire | STOCKHOLM, May 19, 2026 /PRNewswire/ -- Today, the annual general meeting 2026 has been held in SciBase Holding AB (publ) ("SciBase" or the "Company"). The general meeting resolved in accordance... ► Artikel lesen | |
| 18.05. | SciBase Announces New Research Highlighting Nevisense's Potential in Detecting Age-Related Skin Barrier Changes | 351 | PR Newswire | STOCKHOLM, May 18, 2026 /PRNewswire/ -- SciBase Holding AB ("SciBase") (STO: SCIB), a leading developer of AI-based diagnostic solutions for skin disorders, today announced the presentation... ► Artikel lesen | |
| 07.05. | Scibase Holding AB: Interim report | 138 | GlobeNewswire (Europe) | January 1 - March 31, 2026
The first quarter in figures
Net sales were TSEK 14,278 (8,856), +61%, cleared for currency effects +80%.
The loss after tax was TSEK 24,490 (20,682).
The loss per share... ► Artikel lesen | |
| 27.04. | SciBase publishes the Annual report for 2025 | 257 | PR Newswire | STOCKHOLM, April 27, 2026 /PRNewswire/ -- SciBase hereby announces that the Annual report for 2025 is available at the Company's website www.scibase.com.
A pdf-version of the annual... ► Artikel lesen | |
| 14.04. | Notice to attend the annual general meeting in Scibase Holding AB (publ) | 3 | Cision News | ||
| SCIBASE Aktie jetzt für 0€ handeln | |||||
| 07.04. | SciBase reaches milestone with over 400,000 tests sold with Nevisense | 292 | PR Newswire | STOCKHOLM, April 7, 2026 /PRNewswire/ -- SciBase Holding AB ("SciBase") (STO: SCIB), a leading developer of AI-based diagnostic solutions for skin disorders, today announced a significant... ► Artikel lesen | |
| 13.03. | Scibase Holding AB: Interim report | 237 | GlobeNewswire (Europe) | January 1 - December 31, 2025
The fourth quarter in figures
Net sales were TSEK 12,475 (8,598), +45%, cleared for currency effects +57%.
The loss after tax was TSEK 25,300 (21,677).
The loss per... ► Artikel lesen | |
| 10.03. | SciBase: New Study Positions Nevisense's EIS as a valuable and sensitive tool for assessing skin barrier impairment | 448 | PR Newswire | STOCKHOLM, March 10, 2026 /PRNewswire/ -- SciBase Holding AB ("SciBase") (STO: SCIB), a leading developer of AI-based diagnostic solutions for skin disorders, is pleased to announce the publication... ► Artikel lesen | |
| 05.03. | SCIBASE: New Publication: US clinicians' real-world Nevisense experience improves melanoma detection | 3 | Cision News | ||
| 02.03. | SciBase receives approval by FDA for extended labelling in the US | 375 | PR Newswire | STOCKHOLM, March 2, 2026 /PRNewswire/ -- SciBase Holding AB ("SciBase") (STO: SCIB), a leading developer of AI-based diagnostic solutions for skin disorders, today announced that it has received... ► Artikel lesen | |
| 02.03. | Scibase Holding AB: SciBase receives approval by FDA for extended labelling in the US | 354 | GlobeNewswire (Europe) | STOCKHOLM, Sweden - March 2, 2026 - SciBase Holding AB ("SciBase") [STO: SCIB], a leading developer of AI-based diagnostic solutions for skin disorders, today announced that it has received approval... ► Artikel lesen | |
| 19.02. | SciBase's Nevisense (EIS) Included in the US NCCN Guidelines for Melanoma which supports the use of EIS in the detection of melanoma | 348 | PR Newswire | STOCKHOLM, Feb. 19, 2026 /PRNewswire/ -- SciBase Holding AB ("SciBase") (STO: SCIB), a leading developer of AI-based diagnostic solutions for skin disorders, today announced that Nevisense... ► Artikel lesen | |
| 17.02. | SCIBASE: A new study demonstrates that Nevisense can predict atopic dermatitis in Newborns | 2 | Cision News | ||
| 17.02. | Scibase Holding AB: A new study demonstrates that Nevisense can predict atopic dermatitis in Newborns | 692 | GlobeNewswire (Europe) | STOCKHOLM, Sweden - February 17, 2026 - SciBase Holding AB ("SciBase") [STO: SCIB], a leading developer of AI-based diagnostic solutions for skin disorders, announces that results from a new study will... ► Artikel lesen | |
| 06.02. | SciBase: Recalculation of warrants of series TO 2 following rights issue and updated last day of trading in BTA from the rights issue | 354 | PR Newswire | STOCKHOLM, Feb. 6, 2026 /PRNewswire/ -- In accordance with the terms and conditions for warrants of series TO 2, which were issued in connection with the capital raise announced in April... ► Artikel lesen | |
| 27.01. | SciBase announces final outcome of the rights issue and the resolution on a set-off issue within the framework of the offer to repurchase outstanding warrants of series TO 2 | 399 | PR Newswire | STOCKHOLM, Jan. 27, 2026 /PRNewswire/ -- SciBase Holding AB (publ) ("SciBase" or the "Company") today announces the final outcome of the rights issue of shares resolved by the Company on... ► Artikel lesen | |
| 27.01. | Scibase Holding AB: SciBase announces final outcome of the rights issue and the resolution on a set-off issue within the framework of the offer to repurchase outstanding warrants of series TO 2 | 197 | GlobeNewswire (Europe) | SciBase Holding AB (publ) ("SciBase" or the "Company") today announces the final outcome of the rights issue of shares resolved by the Company on 29 December 2025 (the "Rights Issue"). The Rights Issue... ► Artikel lesen |
1 2 3 Weiter >>
49 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| ROKU | 108,28 | -2,43 % | Aurzen Unveils the EAZZE D1R: The UK's First Roku TV Smart Projector for Effortless Big-Screen Streaming | LONDON, June 1, 2026 /PRNewswire/ -- Aurzen today announced the UK launch of the Aurzen Roku TV EAZZE D1R, the country's first smart projector powered by the Roku TV OS.Powered by the intuitive... ► Artikel lesen | |
| SERNOVA BIOTHERAPEUTICS | 0,099 | +4,01 % | Sernova Biotherapeutics: Sernova Biotherapeutics Announces Closing of Recently Approved Financings | Toronto, Ontario and Boston, Massachusetts--(Newsfile Corp. - April 23, 2026) - Sernova Biotherapeutics (TSX: SVA) (OTC: SEOVF) (FSE: PSHO) (XETRA: PSHO) ("Sernova" or the "Company"), a leading... ► Artikel lesen | |
| BOSTON SCIENTIFIC | 40,725 | -1,26 % | Jim Cramer Comments On Boston Scientific and Other Medical Equipment Makers | ||
| PAUL HARTMANN | 206,00 | -1,44 % | Dividendenbekanntmachungen (30.04.2026) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) 4IMPRINT GROUP PLC GB0006640972 1,194 GBP 1,3782 EUR AB DYNAMICS PLC GB00B9GQVG73 0,0308 GBP 0,0355 EUR AGNC INVESTMENT CORP US00123Q1040 0... ► Artikel lesen | |
| SYSMEX | 7,626 | -3,66 % | Sysmex FY Net Profit Declines | BRUSSELS/FRANKFURT/PARIS (dpa-AFX) - Sysmex (6869.T) reported fiscal year profit attributable to owners of the parent of 35.5 billion yen, a decline of 33.9% from prior year. Operating profit... ► Artikel lesen | |
| ADDLIFE | 13,230 | -3,85 % | Dividendenbekanntmachungen (07.05.2026) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) ACCELLERON INDUSTRIES AG ADR US00449R1095 1,8766 USD 1,5973 EUR ACRINOVA AB SE0015660014 3,75 SEK 0,3453 EUR ACRINOVA AB B SE0015660030 3... ► Artikel lesen | |
| EMBECTA | 2,885 | +1,84 % | Dividendenbekanntmachungen (28.05.2026) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) ACTIVIA PROPERTIES INC JP3047490002 3169 JPY 17,0809 EUR ADVANCED MEDICAL SOLUTIONS GROUP PLC GB0004536594 0,0201 GBP 0,0232 EUR AIA... ► Artikel lesen | |
| ENOVIS | 18,500 | -1,07 % | Enovis Corporation: Enovis Announces First Quarter 2026 Results | First-quarter sales growth of 5% on a reported basisFirst-quarter Reconstructive sales grew 11% on a reported basisReiterating full-year 2026 revenue, adjusted EBITDA, adjusted EPS, and Free Cash... ► Artikel lesen | |
| PULMONX | 1,360 | -0,73 % | Pulmonx Corporation Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | ||
| SI-BONE | 11,800 | -1,67 % | Wall Street Analysts Predict a 71.13% Upside in Si-Bone (SIBN): Here's What You Should Know | ||
| REVITALIST LIFESTYLE AND WELLNESS | 0,015 | -100,00 % | Revitalist Lifestyle and Wellness Ltd: Revitalist Lifestyle CEO Walker, CFO Murray resign | ||
| LIFECARE ASA | 0,025 | -13,06 % | Lifecare ASA: Commencement of the Exercise Period for Warrants Series 2 issued in connection with the Rights Issue | ||
| PEIJIA MEDICAL | 0,482 | -2,03 % | PEIJIA-B (09996): VOLUNTARY ANNOUNCEMENT - ACHIEVA MEDICAL ENTERED INTO AN EXCLUSIVE DISTRIBUTION AGREEMENT WITH B. BRAUN MEDICAL | ||
| KOOTH | 2,020 | 0,00 % | Kooth Digital Health Names Fred Bendaña Chief Commercial Officer | Chicago, May 21, 2026 (GLOBE NEWSWIRE) -- Kooth Digital Health announced the appointment of Fred Bendaña as Chief Commercial Officer, a role that will accelerate the growth of Soluna, Kooth's digital... ► Artikel lesen | |
| BACTIGUARD | 1,280 | -0,39 % | Bactiguard Holding AB: Bulletin from Bactiguard Holding AB's (publ) Annual General Meeting | At Bactiguard Holding AB's (publ) Annual General Meeting (AGM) on 19 May 2026, the following resolutions were made:
The AGM adopted the income statements and balance sheets for 2025 and decided that... ► Artikel lesen |
Das Unternehmen SCIBASE HOLDING AB kann der Branche Gesundheitswesen zugeordnet werden. Die relative Kursveränderung beträgt aktuell -8,89 % bei einem Aktienkurs von 0,016 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu SCIBASE HOLDING AB finden Sie auf Wallstreet Online.